Heparin Binding Peptide is one of the heparin-binding amino acid sequences found in the carboxy-terminal heparin-binding domain of fibronectin.
CAT No: R1353
CAS No:125720-21-0
Synonyms/Alias:Fibronectin Adhesion-promoting Peptide;125720-21-0;Heparin binding peptide;FIBRONECTINADHESION-PROMOTINGPEPTIDE;SCHEMBL3089699;(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoic acid;Fibronectin Adhesion-Promoting Peptide trifluoroacetate salt;DTXSID90430998;HY-P0306;DA-63438;FF108476;MS-31873;G12527;Fibronectin Adhesion-promoting Peptide, >=95% (HPLC);H-Trp-Gln-Pro-Pro-Arg-Ala-Arg-Ile-OH; H-WQPPRARI-OH;
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
2. Emu oil in combination with other active ingredients for treating skin imperfections
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.